Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Beta-thalassemia Major
NCT00999349Phase 3Unknown
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron overload comparing Silymarin (LEGALON) with Placebo (2 arms). Primary endpoint: Serum ferritin level at 6 months. Status: unknown.
02
Drugs
silibinin
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT00999349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00999349.